ACTIVE SUBSTANCE / INN

CAPLACIZUMAB-YHDP

Brand name(s): CABLIVI
FDA LISTED
PRESCRIPTION
BLA761112
ACTIVE SUBSTANCE
Caplacizumab-Yhdp
REGULATORS
FDA
SPONSORS / MAH
ABLYNX NV
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
CABLIVIBLA761112ABLYNX NVPrescription

FULL INTELLIGENCE ON CAPLACIZUMAB-YHDP

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →